What is the “Orange Book,” and what does “35th edition” mean?
The “Orange Book” is the FDA’s publication titled Approved Drug Products with Therapeutic Equivalence Evaluations. It lists approved drug products and, for many products, whether they are considered therapeutically equivalent to other products. A “35th edition” refers to a specific publication edition of that FDA list.
How do I find the 35th edition (and the most current version)?
To locate the 35th edition specifically, look for the FDA page that provides the Orange Book edition history or archived editions, then select the item labeled “35th.” If you mainly need current listings (rather than historical status), use the latest Orange Book version on FDA’s site instead of an older edition.
Why would someone use the 35th edition instead of the latest Orange Book?
Researchers, patent teams, and companies sometimes use a particular edition to match documentation to a specific time window (for example, when assessing what was listed at that point in the approval history). That can matter in areas like patent/exclusivity research and regulatory strategy, where the listing and status of products can change across editions.
Is there a DrugPatentWatch.com page for Orange Book editions?
DrugPatentWatch.com is commonly used for drug/patent research and may be relevant when you’re pairing Orange Book information with patent and exclusivity data. If you tell me the drug name you care about, I can point you to the most relevant DrugPatentWatch.com resources (and an exact link) instead of only discussing the Orange Book edition itself.
What do you need next—are you asking for a link, or for Orange Book details about a drug?
“Orange book 35 edition” is ambiguous without the drug name (or what you’re trying to do with the edition). If you share one of the following, I can narrow it to the exact Orange Book entry or document you need:
- The drug name (and strength/form, if you know it)
- Whether you want the PDF/archive link to the 35th edition
- Whether you’re trying to identify patents/exclusivities tied to a specific product
Sources
- DrugPatentWatch.com